Filing Details
- Accession Number:
- 0001061983-22-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-18 17:37:26
- Reporting Period:
- 2022-02-16
- Accepted Time:
- 2022-02-18 17:37:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1288859 | I Robert Blum | 280 East Grand Avenue South San Francisco CA 94080 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-16 | 10,000 | $7.96 | 370,644 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-16 | 10,000 | $36.50 | 360,644 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-02-16 | 5,724 | $0.00 | 366,368 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-02-16 | 8,750 | $0.00 | 375,118 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-02-16 | 10,000 | $0.00 | 10,000 | $7.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 169,208 | 2015-03-26 | 2025-02-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,083 | Indirect | by Trust 1 |
| Common Stock | 2,083 | Indirect | by Trust 2 |
Footnotes
- Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.
- On or about May 11, 2021, the Reporting Person was granted performance-based stock units (PSUs) of the Issuer, which upon satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into fully-vested shares of common stock of the Issuer.
- Comprised of restricted stock units (RSUs) issued upon conversion of certain PSUs granted to the Reporting Person on May 11, 2021. The satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into RSUs of the Issuer. These RSUs will vest in whole on February 16, 2023.
- Shares held by The Bridget Blum 2003 Irrevocable Trust.
- Shares held by The Brittany Blum 2003 Irrevocable Trust.
Billionaire Hedge Funds
